PATENT CLAIM ANALYSIS

Application Number: 15904269
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "093200"]

Abstract:
CRISPR/CAS-related compositions and methods for treatment of Leber's Congenital Amaurosis 10 (LCA10) are disclosed.

Claim (Index 18):
The method of  claim 15 , wherein said viral particle further comprises a nucleotide sequence encoding a second gRNA molecule comprising a second targeting domain complementary with a second target domain from the CEP290 gene, wherein said second targeting domain comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:558 (CEP290-64), SEQ ID NO:2321 (CEP290-11), SEQ ID NO:2312 (CEP290-230), SEQ ID NO:460 (CEP290-496), SEQ ID NO:586 (CEP290-502), and SEQ ID NO:568 (CEP290-504).

Metadata:
- Claim Count in Document: 77.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14644181', '15825616', '14536319', '15832567', '15127087']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7316061661391793
- 35 USC 102 Novelty (BERT): 0.781083723030966
- Combined Prediction Score: 0.736553921828358
- Mean Citation Score: 565.7883320000002
- Max Citation Score: 909.1263
- Similarity Product: 890.2481238683583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test